Guerbet looks for 10% growth in 1995
This article was originally published in Clinica
Executive Summary
Profits at French contrast media manufacturer Guerbet were up 9.2% to Fr 56 million ($11.4 million) in 1994 compared with 1993. Group turnover for the year was Fr 936.8 million, a rise of 3%, while R&D spending, which represented some 11% of revenues, totalled Fr 109 million. The company is expecting more rapid growth in 1995 than last year with larger profits in spite of product launches, says board president Dr Michel Guerbet in the company's annual report.